Bank Julius Baer & Co. Ltd, Zurich Abiomed Inc Transaction History

Bank Julius Baer & Co. Ltd, Zurich

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$300.63 - $371.35 $30,363 - $37,506	-101 Reduced 17.47%	477 $171,000
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $5,273 - $6,395	17 Added 3.03%	578 $188,000
Q2 2021 Jul 23, 2021	SELL	$262.71 - $351.17 $1,576 - $2,107	-6 Reduced 1.06%	561 $175,000
Q1 2021 May 10, 2021	SELL	$285.92 - $355.13 $52,323 - $64,988	-183 Reduced 24.4%	567 $181,000
Q4 2020 Feb 24, 2021	SELL	$251.88 - $324.2 $523,658 - $674,011	-2,079 Reduced 73.49%	750 $243,000
Q4 2020 Feb 12, 2021	SELL	$251.88 - $324.2 $391,925 - $504,455	-1,556 Reduced 35.48%	2,829 $243,000
Q3 2020 Nov 10, 2020	SELL	$255.22 - $317.0 $116,635 - $144,869	-457 Reduced 9.44%	4,385 $1.22 Million
Q2 2020 Aug 12, 2020	SELL	$141.4 - $257.09 $1,555 - $2,827	-11 Reduced 0.23%	4,842 $1.17 Million
Q1 2020 May 13, 2020	BUY	$130.51 - $196.01 $633,365 - $951,236	4,853 New	4,853 $704,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.